Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Apr 07, 2022 10:25am
109 Views
Post# 34584009

RE:I was hoping for a takeover offer

RE:I was hoping for a takeover offeragreed.  if you didnt get out when you could your hooped and they dont care.  Its obviously why Matt has yet to buy any shares and no other insider has in forever even at historical low SP

All they really care about is keeping a paycheck so selling out for peanuts doesnt bother them as long as they are given jobs by whichever company is foolish enough to even think about buying them.

Just imagine if the genius Tripp had done this instead.
Apr 1 2021 - We are proud to annouce the official release of the premium early detection cancer test Aristotle to the public.
Apr 2 2021 - We are pround to annouce our first partner in the release of Aristotle, CARE oncology.

They could had coasted on that for the next year.  SP would had jumped to 2 bucks or more instantly.  A buyout would had been much more likely.

Instead they chose to buy out a company to hopefully force sales through them.  

If CARE was doing $4M a year before (according to Tripp) then that means $1M of the last Q4 was thanks to them.  So between Aristotle and Covid Stage themselves only did $500K.  That doesnt seem to worry any of the pumpers.  Or maybe we cant trust Tripps word on the $4M???? At least it wasnt $30M again eh.

Where did all the talk of "NASDAQ" go? ha
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse